Eligibility Module

Eligibility Module

The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.

Eligibility Module path is as follows:

Study -> Protocol Section -> Eligibility Module

Eligibility Module


Ignite Creation Date: 2025-12-24 @ 11:14 PM
Ignite Modification Date: 2025-12-24 @ 11:14 PM
NCT ID: NCT05028569
Eligibility Criteria: Inclusion Criteria: * History of migraine headache disorder meeting International Classification of Headache Disorders (ICHD)-3 diagnostic criteria for migraine with aura or migraine without aura for \>= 12 months. * Onset of migraine before 50 years of age. * History of 6 to 14 migraine days/month in each of the 3 months prior to Visit 1. * Six to 14 migraine/probable migraine days during the 4-week screening/baseline phase. * Less than 15 headache days/month in each of the 3 months prior to Visit 1 and during the 4-week screening/baseline phase. Exclusion Criteria: * Current diagnosis of chronic migraine according to ICHD-3. * History or current diagnosis of migraine with brainstem aura, retinal migraine, complications of migraine, chronic tension-type headache, trigeminal autonomic cephalalgias, hypnic headache, hemicrania continua, or new daily persistent headache. * History of headache attributed to another disorder (e.g., cervical dystonia, craniotomy, head/neck trauma) with exception that medication overuse headache per ICHD-3 criteria is allowed. * History of inadequate response to \> 4 prophylactic treatment for migraine, 2 of which have different mechanisms of action. * Female who is pregnant, breastfeeding, or considering becoming pregnant during the study or within 90 days after the last dose of study drug.
Healthy Volunteers: False
Sex: ALL
Minimum Age: 18 Years
Maximum Age: 65 Years
Study: NCT05028569
Study Brief:
Protocol Section: NCT05028569